-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tipifarnib in Squamous Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tipifarnib in Squamous Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tipifarnib in Squamous Non-Small Cell Lung Cancer Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tipifarnib in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tipifarnib in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tipifarnib in Head And Neck Squamous Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tipifarnib in Recurrent Head And Neck Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tipifarnib in Recurrent Head And Neck Squamous Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tipifarnib in Recurrent Head And Neck Squamous...
-
Analyst Opinions
Meal Replacement Sports and Energy Products – Fad or Trend?
Meal Replacement Products Report Overview The meal replacement products market size was $6.79 billion in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2027. As the demand for convenient formats aiding in weight loss remains strong worldwide, the meal replacement market is expected to continue to grow until 2027. The market's momentum is consistently positive, with some inflationary pressure on prices expected as vegan and other increasingly specialized diet options result in new...
-
Sector Analysis
NewBlockchain Market Trends and Analysis by Region, Application, Vertical and Segment Forecast to 2030
Accessing the in-depth insights from the ‘Blockchain’ report can help: Understand the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust the business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Blockchain’ report different from other reports...
-
Sector Analysis
Infusion Pumps Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Infusion Pumps Market Overview The infusion pumps market size was valued at $2.64 billion in 2023. The infusion pumps market will grow at a CAGR of more than 2% from 2023 to 2033. The infusion pump is a commonly used medical device for patients with chronic conditions such as cancer and diabetes used at hospitals, homes, and healthcare centers. Infusion pumps successfully address the delivery-related problems that have serious implications on patient safety, with their ability to administer fluids, medication,...
-
Analyst Opinions
Digitalization – MegaTrend Overview and TrendSights Analysis, 2023
Digitalization - Consumer TrendSights Report Overview Digital technologies are increasingly enhancing brand operations and providing benefits for consumers in the FMCG space. The benefits include providing increased efficiency as well as improved connectivity across all product categories. The innovations are also increasing convenience for consumers, saving them time, informing shopping choices, and enabling self-expression through social media and products that align with individual values. TrendSights Framework: Digitalization Buy the Full Report for More Insights into the Digitalization Mega-Trend Download a...
-
Analyst Opinions
What Opportunities do Planned Impulse Occasions Offer Food and Drinks Brands?
Opportunities for Food and Drinks Brands on Planned Impulse Occasions Overview Purchase decisions can generally be categorized into planned purchases or impulse purchases. However, there is a third category that is present at the intersection of these two purchase behaviors. "Planned impulse" purchases reflect elements of need-based purchasing as well as unplanned decisions in-store. It refers to an unintended change to a planned purchase triggered by a discount or promotion. The “What Opportunities Do Planned Impulse Occasions Offer Food and...
-
Thematic Analysis
Demographics in Banking – Thematic Intelligence
Demographics in Banking Thematic Report Overview Demographic mega-trends around birth rates, migration, and aging are intersecting with rising geo-political tensions, de-globalization, inflation, and a host of other social will have profound implications for the development of financial services across the value chain. The demographics in the banking theme report offer a comprehensive analysis of the demographics framework, key trends shaping the demographics, and insights about the key players in this theme. Key Trends ·       Technology Trends ·       Macroeconomic and Social...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDTX-1535 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDTX-1535 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BDTX-1535 in Glioblastoma Multiforme (GBM) Drug Details:BDTX-1535 is under development for the...